Apoptosis induction in primary human colorectal cancer cell lines and retarded tumor growth in SCID mice by sulforaphane

Yi Chiang Hsu, Ming Jenn Chen, Wei Yu Tang, Che Wei Hsu, Ya Ting Tsai, June Fu Wu, Chen Wei Lin, Ya-Min Cheng

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

We have investigated the anticancer effects of the dietary isothiocyanate sulforaphane (SFN) on colorectal cancer (CRC), using primary cancer cells lines isolated from five Taiwanese colorectal cancer patients as the model for colorectal cancer. SFN-treated cells accumulated in metaphase (SFN 6.25μM) and subG1 (SFN 12.5 and 25μM) as determined by flow cytometry. In addition, treated cells showed nuclear apoptotic morphology that coincided with an activation of caspase-3, and loss of mitochondrial membrane potential (Δ Ψm). Incubations at higher SFN doses (12.5 and 25μM) resulted in cleavage of procaspase-3 and elevated caspase-2, -3, -8, and -9 activity, suggesting that the induction of apoptosis and the sulforaphane-induced mitosis delay at the lower dose are independently regulated. Daily SFN s.c. injections (400micromol/kg/d for 3 weeks) in severe combined immunodeficient mice with primary human CRC (CP1 to CP5) s.c. tumors resulted in a decrease of mean tumor weight by 70 compared with vehicle-treated controls. Our findings suggest that, in addition to the known effects on cancer prevention, sulforaphane may have antitumor activity in established colorectal cancer.

Original languageEnglish
Article number415231
JournalEvidence-based Complementary and Alternative Medicine
Volume2012
DOIs
Publication statusPublished - 2012 Jan 1

Fingerprint

SCID Mice
Tumor Cell Line
Colorectal Neoplasms
Apoptosis
Growth
Caspase 3
Caspase 2
Neoplasms
sulforafan
Mitochondrial Membrane Potential
Metaphase
Tumor Burden
Mitosis
Flow Cytometry
Cell Line
Injections

All Science Journal Classification (ASJC) codes

  • Complementary and alternative medicine

Cite this

Hsu, Yi Chiang ; Chen, Ming Jenn ; Tang, Wei Yu ; Hsu, Che Wei ; Tsai, Ya Ting ; Wu, June Fu ; Lin, Chen Wei ; Cheng, Ya-Min. / Apoptosis induction in primary human colorectal cancer cell lines and retarded tumor growth in SCID mice by sulforaphane. In: Evidence-based Complementary and Alternative Medicine. 2012 ; Vol. 2012.
@article{88001d1b00774c9a94c003b222754f41,
title = "Apoptosis induction in primary human colorectal cancer cell lines and retarded tumor growth in SCID mice by sulforaphane",
abstract = "We have investigated the anticancer effects of the dietary isothiocyanate sulforaphane (SFN) on colorectal cancer (CRC), using primary cancer cells lines isolated from five Taiwanese colorectal cancer patients as the model for colorectal cancer. SFN-treated cells accumulated in metaphase (SFN 6.25μM) and subG1 (SFN 12.5 and 25μM) as determined by flow cytometry. In addition, treated cells showed nuclear apoptotic morphology that coincided with an activation of caspase-3, and loss of mitochondrial membrane potential (Δ Ψm). Incubations at higher SFN doses (12.5 and 25μM) resulted in cleavage of procaspase-3 and elevated caspase-2, -3, -8, and -9 activity, suggesting that the induction of apoptosis and the sulforaphane-induced mitosis delay at the lower dose are independently regulated. Daily SFN s.c. injections (400micromol/kg/d for 3 weeks) in severe combined immunodeficient mice with primary human CRC (CP1 to CP5) s.c. tumors resulted in a decrease of mean tumor weight by 70 compared with vehicle-treated controls. Our findings suggest that, in addition to the known effects on cancer prevention, sulforaphane may have antitumor activity in established colorectal cancer.",
author = "Hsu, {Yi Chiang} and Chen, {Ming Jenn} and Tang, {Wei Yu} and Hsu, {Che Wei} and Tsai, {Ya Ting} and Wu, {June Fu} and Lin, {Chen Wei} and Ya-Min Cheng",
year = "2012",
month = "1",
day = "1",
doi = "10.1155/2012/415231",
language = "English",
volume = "2012",
journal = "Evidence-based Complementary and Alternative Medicine",
issn = "1741-427X",
publisher = "Hindawi Publishing Corporation",

}

Apoptosis induction in primary human colorectal cancer cell lines and retarded tumor growth in SCID mice by sulforaphane. / Hsu, Yi Chiang; Chen, Ming Jenn; Tang, Wei Yu; Hsu, Che Wei; Tsai, Ya Ting; Wu, June Fu; Lin, Chen Wei; Cheng, Ya-Min.

In: Evidence-based Complementary and Alternative Medicine, Vol. 2012, 415231, 01.01.2012.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Apoptosis induction in primary human colorectal cancer cell lines and retarded tumor growth in SCID mice by sulforaphane

AU - Hsu, Yi Chiang

AU - Chen, Ming Jenn

AU - Tang, Wei Yu

AU - Hsu, Che Wei

AU - Tsai, Ya Ting

AU - Wu, June Fu

AU - Lin, Chen Wei

AU - Cheng, Ya-Min

PY - 2012/1/1

Y1 - 2012/1/1

N2 - We have investigated the anticancer effects of the dietary isothiocyanate sulforaphane (SFN) on colorectal cancer (CRC), using primary cancer cells lines isolated from five Taiwanese colorectal cancer patients as the model for colorectal cancer. SFN-treated cells accumulated in metaphase (SFN 6.25μM) and subG1 (SFN 12.5 and 25μM) as determined by flow cytometry. In addition, treated cells showed nuclear apoptotic morphology that coincided with an activation of caspase-3, and loss of mitochondrial membrane potential (Δ Ψm). Incubations at higher SFN doses (12.5 and 25μM) resulted in cleavage of procaspase-3 and elevated caspase-2, -3, -8, and -9 activity, suggesting that the induction of apoptosis and the sulforaphane-induced mitosis delay at the lower dose are independently regulated. Daily SFN s.c. injections (400micromol/kg/d for 3 weeks) in severe combined immunodeficient mice with primary human CRC (CP1 to CP5) s.c. tumors resulted in a decrease of mean tumor weight by 70 compared with vehicle-treated controls. Our findings suggest that, in addition to the known effects on cancer prevention, sulforaphane may have antitumor activity in established colorectal cancer.

AB - We have investigated the anticancer effects of the dietary isothiocyanate sulforaphane (SFN) on colorectal cancer (CRC), using primary cancer cells lines isolated from five Taiwanese colorectal cancer patients as the model for colorectal cancer. SFN-treated cells accumulated in metaphase (SFN 6.25μM) and subG1 (SFN 12.5 and 25μM) as determined by flow cytometry. In addition, treated cells showed nuclear apoptotic morphology that coincided with an activation of caspase-3, and loss of mitochondrial membrane potential (Δ Ψm). Incubations at higher SFN doses (12.5 and 25μM) resulted in cleavage of procaspase-3 and elevated caspase-2, -3, -8, and -9 activity, suggesting that the induction of apoptosis and the sulforaphane-induced mitosis delay at the lower dose are independently regulated. Daily SFN s.c. injections (400micromol/kg/d for 3 weeks) in severe combined immunodeficient mice with primary human CRC (CP1 to CP5) s.c. tumors resulted in a decrease of mean tumor weight by 70 compared with vehicle-treated controls. Our findings suggest that, in addition to the known effects on cancer prevention, sulforaphane may have antitumor activity in established colorectal cancer.

UR - http://www.scopus.com/inward/record.url?scp=80052707191&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052707191&partnerID=8YFLogxK

U2 - 10.1155/2012/415231

DO - 10.1155/2012/415231

M3 - Article

C2 - 21804859

AN - SCOPUS:80052707191

VL - 2012

JO - Evidence-based Complementary and Alternative Medicine

JF - Evidence-based Complementary and Alternative Medicine

SN - 1741-427X

M1 - 415231

ER -